[
    "{\"step_by_step_thinking\": \"Lenacapavir is mentioned in multiple documents as an investigational drug for the treatment of HIV. Document [1] states that lenacapavir is an investigational first-in-class agent that disrupts functioning of HIV capsid protein across multiple steps in the viral life cycle. Document [2] mentions that lenacapavir is being developed by Gilead Sciences as a treatment for HIV patients infected with multidrug-resistant virus and as a twice-yearly injectable for pre-exposure prophylaxis (PrEP). Document [6] mentions that lenacapavir received its first approval in the EU for use in combination with other antiretroviral(s) in adults with multi-drug resistant HIV infection. Based on this information, the answer is A. yes, lenacapavir can be used for HIV.\", \"answer_choice\": \"A\"}"
]